about
Chikungunya Virus Infection: An Update on Joint Manifestations and ManagementThe Synthetic Antiviral Drug Arbidol Inhibits Globally Prevalent Pathogenic VirusesInvestigational hemagglutinin-targeted influenza virus inhibitors.Structural basis of influenza virus fusion inhibition by the antiviral drug Arbidol.Iminosugars: Promising therapeutics for influenza infection.Broad-spectrum antivirals against viral fusion.The delivery of arbidol by salt engineering: synthesis, physicochemical properties and pharmacokinetics.The cytokine storm of severe influenza and development of immunomodulatory therapyAntiviral drug discovery: broad-spectrum drugs from nature.Rates and effectiveness of antiviral use among hospitalized influenza patients.Broad-spectrum antiviral agents.The Location of the Protonated and Unprotonated Forms of Arbidol in the Membrane: A Molecular Dynamics Study.Structure-based optimization and synthesis of antiviral drug Arbidol analogues with significantly improved affinity to influenza hemagglutinin.Antiviral Strategies Against Chikungunya Virus.Molecular basis of influenza hemagglutinin inhibition with an entry-blocker peptide by computational docking and mass spectrometry.Chikungunya: vaccines and therapeutics.Current Strategies for Inhibition of Chikungunya Infection.The Antiviral Drug Arbidol Inhibits Zika Virus.Structural analogs of umifenovir 2*. The synthesis and antiHIV activity study of new regioisomeric (trans-2-phenylcyclopropyl)-1Н-indole derivatives
P2860
Q27928037-CE372238-10B8-4FE6-BF01-CFFE60DD91E8Q28271798-76D60E9D-5AF7-47EC-982F-5D3DF4317C69Q30240175-AAB65385-BBB1-42FE-B9BF-A80C55C95A1AQ30396717-FCFE29D8-47DD-413C-A2CD-AD3959106F23Q33795341-98071CB7-59BA-427A-8607-1B34C36EDD48Q36010083-20C10200-B2D9-43D5-8D94-84595704A5C7Q36105894-BDED339F-8EE9-4E2B-95FC-34527C1DE1DBQ36459143-68D97FED-10CE-4956-A2C8-FFBC69EC2334Q38260235-274674EB-2F1E-4D17-A4F0-5A311543101DQ38476530-613DD44B-DC33-4216-9F0A-30C73F4A23F5Q38519881-2FBADA5F-161E-4D70-94BB-BAE003C3DACDQ40026277-598BE4F8-E22C-4971-999A-6800F56C25CBQ40130250-C34E1E72-9853-41B1-A827-7C592CE2FDE5Q40656579-2E1ACEA8-F2C5-4786-82C5-F909B36E52F6Q40982127-224ECCD0-EF48-497F-B8E5-BF64136B9DD5Q47098677-B018A8F1-4D89-4FE3-B737-0C67C4327C6AQ54214355-8DAA7E88-97A1-42E9-B9C3-902CF35D08E6Q55084371-906FFB8E-F4A0-4990-AD04-30AE1D85643CQ56763273-E6E3CE9C-2F15-4B6F-82F4-75953A2288E4
P2860
description
2014 nî lūn-bûn
@nan
2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Arbidol as a broad-spectrum antiviral: an update.
@ast
Arbidol as a broad-spectrum antiviral: an update.
@en
Arbidol as a broad-spectrum antiviral: an update.
@nl
type
label
Arbidol as a broad-spectrum antiviral: an update.
@ast
Arbidol as a broad-spectrum antiviral: an update.
@en
Arbidol as a broad-spectrum antiviral: an update.
@nl
prefLabel
Arbidol as a broad-spectrum antiviral: an update.
@ast
Arbidol as a broad-spectrum antiviral: an update.
@en
Arbidol as a broad-spectrum antiviral: an update.
@nl
P2093
P1433
P1476
Arbidol as a broad-spectrum antiviral: an update.
@en
P2093
Eve-Isabelle Pécheur
Julie Blaising
Stephen J Polyak
P356
10.1016/J.ANTIVIRAL.2014.04.006
P577
2014-04-24T00:00:00Z